Staging in patients with locoregionally recurrent breast cancer: current practice and prospects for positron emission tomography

被引:23
|
作者
van Oost, FJ
van der Hoeven, JJM
Hoekstra, OS
Voogd, AC
Coebergh, JWW
van de Poll-Franse, LV
机构
[1] Comprehens Canc Ctr S, IKZ, Eindhoven Canc Registry, NL-5600 AE Eindhoven, Netherlands
[2] Ziekenhuis Amstelveen, Dept Internal Med, Amstelveen, Netherlands
[3] Vrije Univ Amsterdam, Med Ctr, Dept Nucl Med, PET, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands
[5] Maastricht Univ, Dept Epidemiol, Maastricht, Netherlands
[6] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands
关键词
breast cancer; recurrence; staging; 2-fluoro-2-deoxy-D-glucose; positron emission tomography; PET;
D O I
10.1016/j.ejca.2004.03.012
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The aim of this study was to describe the extent and yield of daily clinical practice when staging patients with a locoregional recurrence (LRR) of breast carcinoma and to explore the prospects for positron emission tomography (PET). The population-based Eindhoven Cancer Registry was used to select all breast cancer patients in the southeast of the Netherlands with a first episode of LRR between January 1, 1994 and June 30, 2000 (n = 175). Additional data concerning staging procedures and follow-up were collected from the medical records. Furthermore, we asked 77 physicians (response: 75%) about their opinions on staging procedures and actual treatment policy. At LRR presentation, 16% of patients were found to have distant metastases. An additional 24% were diagnosed with distant metastases within 18 months. The questionnaire revealed that 33% of clinicians thought that the sensitivity of conventional imaging techniques was too low. We tend to conclude that in daily clinical practice there is a need for more sensitive dissemination tests for patients with a LRR of breast cancer. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1545 / 1553
页数:9
相关论文
共 50 条
  • [41] Comparison of Positron Emission Tomography, Computed Tomography, and Endoscopic Ultrasound in the Initial Staging of Patients with Esophageal Cancer
    Val J. Lowe
    Fargol Booya
    J. G. Fletcher
    Mark Nathan
    Eric Jensen
    Brian Mullan
    Eric Rohren
    Maurits J. Wiersema
    Enrique Vazquez-Sequeiros
    Joseph A. Murray
    Mark S. Allen
    Michael J. Levy
    Jonathan E. Clain
    Molecular Imaging and Biology, 2005, 7 : 422 - 430
  • [42] Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer
    Lowe, VJ
    Booya, F
    Fletcher, JG
    Nathan, M
    Jensen, E
    Mullan, B
    Rohren, E
    Wiersema, MJ
    Vazquez-Sequeiros, E
    Murray, JA
    Allen, MS
    Levy, MJ
    Clain, JE
    MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (06) : 422 - 430
  • [43] The Role of 18F-FDG-Positron Emission Tomography/Computed Tomography in Staging Primary Breast Cancer
    Niikura, Naoki
    Ueno, Naoto T.
    JOURNAL OF CANCER, 2010, 1 : 51 - 53
  • [44] Positron Emission Tomography–Computed Tomography in Oesophageal Cancer Staging: A Tailored Approach
    David M. Bunting
    Wesley W. Lai
    Richard G. Berrisford
    Tim J. Wheatley
    Brent Drake
    Grant Sanders
    World Journal of Surgery, 2015, 39 : 1000 - 1007
  • [45] Positron emission tomography for staging of oesophageal and gastroesophageal malignancy
    Kole, AC
    Plukker, JT
    Nieweg, OE
    Vaalburg, W
    BRITISH JOURNAL OF CANCER, 1998, 78 (04) : 521 - 527
  • [46] Fluorodeoxyglucose positron emission tomography/computed tomography findings after percutaneous cryoablation of early breast cancer
    Adachi, Takuya
    Machida, Youichi
    Fukuma, Eisuke
    Tateishi, Ukihide
    CANCER IMAGING, 2020, 20 (01)
  • [47] The current status of positron emission mammography in breast cancer diagnosis
    Vasileios Kalles
    George C. Zografos
    Xeni Provatopoulou
    Dimitra Koulocheri
    Antonia Gounaris
    Breast Cancer, 2013, 20 : 123 - 130
  • [48] The current status of positron emission mammography in breast cancer diagnosis
    Kalles, Vasileios
    Zografos, George C.
    Provatopoulou, Xeni
    Koulocheri, Dimitra
    Gounaris, Antonia
    BREAST CANCER, 2013, 20 (02) : 123 - 130
  • [49] Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients
    Takamochi, K
    Yoshida, J
    Murakami, K
    Niho, S
    Ishii, G
    Nishimura, M
    Nishiwaki, Y
    Suzuki, K
    Nagai, K
    LUNG CANCER, 2005, 47 (02) : 235 - 242
  • [50] [18F]-fluorodeoxyglucose positron emission tomography in patients with suspected recurrence of breast cancer
    Kamel, EM
    Wyss, MT
    Fehr, MK
    von Schulthess, GK
    Goerres, GW
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2003, 129 (03) : 147 - 153